Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nephros (NEPH) Debt to Equity (2016 - 2022)

Historic Debt to Equity for Nephros (NEPH) over the last 9 years, with Q4 2022 value amounting to $0.02.

  • Nephros' Debt to Equity fell 1720.53% to $0.02 in Q4 2022 from the same period last year, while for Dec 2022 it was $0.02, marking a year-over-year decrease of 1720.53%. This contributed to the annual value of $0.02 for FY2022, which is 1720.53% down from last year.
  • Per Nephros' latest filing, its Debt to Equity stood at $0.02 for Q4 2022, which was down 1720.53% from $0.01 recorded in Q3 2022.
  • In the past 5 years, Nephros' Debt to Equity registered a high of $0.63 during Q1 2018, and its lowest value of $0.01 during Q3 2022.
  • Its 5-year average for Debt to Equity is $0.14, with a median of $0.06 in 2020.
  • As far as peak fluctuations go, Nephros' Debt to Equity crashed by 9231.1% in 2018, and later surged by 477.73% in 2022.
  • Quarter analysis of 5 years shows Nephros' Debt to Equity stood at $0.27 in 2018, then crashed by 43.45% to $0.15 in 2019, then plummeted by 70.07% to $0.05 in 2020, then tumbled by 49.06% to $0.02 in 2021, then fell by 17.21% to $0.02 in 2022.
  • Its last three reported values are $0.02 in Q4 2022, $0.01 for Q3 2022, and $0.03 during Q2 2022.